TBPH Stock Ownership Activity

THERAVANCE BIOPHARMA INC 13F holders

1 value investing guru has made changes to the THERAVANCE BIOPHARMA INC (TBPH) position according to the gurus' latest SEC quarterly report(s). TBPH has been completely sold out by 1 guru(s)

Which gurus or hedge funds are buying TBPH now?

According to the latest SEC filing(s) THERAVANCE BIOPHARMA INC (TBPH) has not been purchased by any super investor.

To see more about who is investing in THERAVANCE BIOPHARMA INC (TBPH), please go to the TBPH ownership page.

2024 Q3 (1 result)
Seth Klarman
-100.00%
-4,200,021
-1.02%
0.00%
Current price: $9.59 13.09% Reported price*: $8.48
2024 Q2 (1 result)
Seth Klarman
-36.31%
-2,394,105
-0.57%
0.00%
Current price: $9.59 13.09% Reported price*: $8.48
2024 Q1 (1 result)
Seth Klarman
-11.12%
-825,100
-0.21%
1.67%
Current price: $9.59 6.91% Reported price*: $8.97
2023 Q2 (1 result)
Seth Klarman
-28.79%
-3,000,000
-0.56%
1.39%
Current price: $9.59 7.34% Reported price*: $10.35
2023 Q1 (1 result)
Seth Klarman
-8.76%
-905,000
-0.19%
1.76%
Current price: $9.59 11.61% Reported price*: $10.85
2022 Q4 (1 result)
Seth Klarman
-14.90%
-2,000,000
-0.37%
2.10%
Current price: $9.59 14.53% Reported price*: $11.22
2022 Q2 (1 result)
Seth Klarman
-1.64%
-224,107
-0.03%
1.80%
Current price: $9.59 5.85% Reported price*: $9.06
2022 Q1 (1 result)
Seth Klarman
-0.12%
-14,898
-0.00%
1.24%
Current price: $9.59 0.31% Reported price*: $9.56
2021 Q3 (1 result)
Seth Klarman
+37.84%
+3,468,750
+0.26%
0.86%
Current price: $9.59 29.59% Reported price*: $7.40
2021 Q2 (1 result)
Seth Klarman
+13.45%
+1,175,000
+0.14%
1.17%
Current price: $9.59 33.95% Reported price*: $14.52
2020 Q3 (1 result)
Seth Klarman
-6.17%
-574,000
-0.09%
1.40%
Current price: $9.59 35.14% Reported price*: $14.78
2017 Q3 (1 result)
Seth Klarman
+0.38%
+35,177
+0.02%
3.99%
Current price: $9.59 71.99% Reported price*: $34.24
2016 Q4 (1 result)
Seth Klarman
+26.16%
+1,923,000
+0.81%
3.89%
Current price: $9.59 69.92% Reported price*: $31.88
2016 Q3 (1 result)
Michael Burry
-100.00%
-325,000
-20.84%
0.00%
Current price: $9.59 57.73% Reported price*: $22.69
2016 Q2 (2 results)
Michael Burry
+18.18%
+50,000
+2.49%
0.00%
Seth Klarman
+13.07%
+850,000
+0.26%
2.28%
Current price: $9.59 57.73% AVG reported price*: $22.69
2016 Q1 (2 results)
Seth Klarman
+1.26%
+80,963
+0.02%
1.78%
Michael Burry
-37.02%
-161,626
-5.95%
10.12%
Current price: $9.59 48.99% AVG reported price*: $18.80
2015 Q4 (1 result)
Michael Burry
buy
+255,426
+8.95%
5.24%
Current price: $9.59 41.49% Reported price*: $16.39
2015 Q2 (1 result)
Seth Klarman
+0.84%
+40,088
+0.01%
1.05%
Current price: $9.59 26.34% Reported price*: $13.02
2015 Q1 (1 result)
Seth Klarman
+5.04%
+305,349
+0.09%
1.87%
Current price: $9.59 44.73% Reported price*: $17.35
2014 Q2 (1 result)
Seth Klarman
buy
+6,061,228
+3.15%
3.15%
Current price: $9.59 69.92% Reported price*: $31.88
22 of 22

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.